AI Assistant
Blog
Pricing
Log In
Sign Up
C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.